8-KEarnings & ResultsLeadership ChangesExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (Aug 6, 2012)

Filed August 6, 2012For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on August 6, 2012, primarily reporting its financial results for the quarter ended June 30, 2012, via an attached press release. While specific financial figures from the press release are not detailed within the 8-K text itself, the filing signals that the company is providing updates on its operational and financial performance to the market. Investors should refer to the furnished press release (Exhibit 99.01) for the detailed financial outcomes of the second quarter of 2012. Additionally, the filing announced a significant internal management change. Steven Pacelli transitioned from Chief Operating Officer to Executive Vice President, Strategy and Corporate Development. This role shift indicates a strategic focus on business development, strategic relationships, investor relations, legal, and intellectual property, while operational leadership will be distributed between the CEO and President. The company will no longer have a dedicated Chief Operating Officer.

Key Highlights

  • 1DexCom, Inc. reported its financial results for the quarter ended June 30, 2012, via a press release filed as an exhibit.
  • 2The company announced a change in executive responsibilities, effective August 6, 2012.
  • 3Steven Pacelli transitioned from Chief Operating Officer (COO) to Executive Vice President, Strategy and Corporate Development.
  • 4Mr. Pacelli will now focus on business development, strategic relationships, investor relations, legal, and intellectual property.
  • 5DexCom will not have a principal operating officer going forward.
  • 6Operational responsibilities will be shared between the CEO, Terry Gregg, and President, Kevin Sayer.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report DexCom's financial results for the quarter ended June 30, 2012, which were released through a press release furnished as an exhibit to this filing. It also reports a significant change in executive roles.

The 8-K filing itself does not contain the specific financial figures from the quarter ended June 30, 2012. Investors need to refer to the press release, Exhibit 99.01, which is incorporated by reference, for detailed financial results.

Steven Pacelli's role changed from Chief Operating Officer to Executive Vice President, Strategy and Corporate Development. This change shifts his focus to strategic initiatives and corporate development, with operational duties being redistributed.

No, following Steven Pacelli's role change, DexCom will not have a principal operating officer. His former operational responsibilities will be split between the Chief Executive Officer and the President.